Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer

[1]  P. Lipponen,et al.  Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer , 2005, Journal of Cancer Research and Clinical Oncology.

[2]  T. Wilt,et al.  Surgery versus radiotherapy for muscle invasive bladder cancer? , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  J. Dunst,et al.  Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. , 2002, International journal of radiation oncology, biology, physics.

[4]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[5]  S. Fosså,et al.  p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder , 2001, BJU international.

[6]  A. Hart,et al.  Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. , 2001, International journal of radiation oncology, biology, physics.

[7]  J. Bartek,et al.  Pathways governing G1/S transition and their response to DNA damage , 2001, FEBS letters.

[8]  J. Wang,et al.  Role of retinoblastoma tumor suppressor protein in DNA damage response. , 2001, Acta oncologica.

[9]  L. True,et al.  The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. , 2000, The oncologist.

[10]  M. Droller.  Grading and staging of bladder carcinoma in transurethral resection specimens: correlation with 105 matched cystectomy specimens. , 2000, The Journal of urology.

[11]  K. Knudsen,et al.  RB-Dependent S-Phase Response to DNA Damage , 2000, Molecular and Cellular Biology.

[12]  G. Steinberg,et al.  The current status of bladder preservation in the treatment of muscle invasive bladder cancer. , 2000, The Journal of urology.

[13]  M. Droller.  Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide. , 2000, The Journal of urology.

[14]  J. Cheville,et al.  Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. , 2000, American journal of clinical pathology.

[15]  H. von der Maase,et al.  Radiotherapy in bladder cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  J. Ribeiro,et al.  Heterogeneity of in vitro radiosensitivity in human bladder cancer cells. , 1999, Radiation oncology investigations.

[17]  C. Dinney,et al.  p53 and RB expression predict progression in T1 bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  S. Groshen,et al.  Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. , 1998, Cancer research.

[19]  B. Czerniak,et al.  Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  C. Cordon-Cardo,et al.  Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. , 1997, Cancer research.

[21]  B. Czerniak,et al.  Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. , 1997, International journal of radiation oncology, biology, physics.

[22]  R. Bergström,et al.  p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy. , 1995, European urology.

[23]  R. Sauer,et al.  Organ-sparing treatment of advanced bladder cancer: a 10-year experience. , 1994, International journal of radiation oncology, biology, physics.

[24]  W. Benedict,et al.  Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti‐RB antibodies , 1994, International journal of cancer.

[25]  S. Fosså,et al.  Bladder cancer definitive radiation therapy of muscle‐invasive bladder cancer: A retrospective analysis of 317 patients , 1993, Cancer.

[26]  A. Sahin,et al.  Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. , 1992, Journal of the National Cancer Institute.

[27]  C. Cordon-Cardo,et al.  Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. , 1992, Journal of the National Cancer Institute.

[28]  W. Shipley,et al.  Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  P. Bassi,et al.  Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. , 1991, The Journal of urology.

[30]  L. Solin,et al.  Prognostic factors in patients with bladder carcinoma treated with definitive irradiation , 1990, Cancer.

[31]  J. Herman,et al.  Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. , 1989, The Journal of urology.

[32]  G. Moberger,et al.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. , 1965, Acta chirurgica Scandinavica.